Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koch, P.
Right arrow Articles by Tiemann, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koch, P.
Right arrow Articles by Tiemann, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 19, Issue 18 (September), 2001: 3861-3873
© 2001 American Society for Clinical Oncology

Primary Gastrointestinal Non-Hodgkin’s Lymphoma: I. Anatomic and Histologic Distribution, Clinical Features, and Survival Data of 371 Patients Registered in the German Multicenter Study GIT NHL 01/92

By Peter Koch, Francisco del Valle, Wolfgang E. Berdel, Normann A. Willich, Berthold Reers, Wolfgang Hiddemann, Bernward Grothaus-Pinke, Gabriele Reinartz, Jens Brockmann, Altfried Temmesfeld, Rudolf Schmitz, Christian Rübe, Andreas Probst, Gert Jaenke, Heinrich Bodenstein, Arved Junker, Christiane Pott, Jürgen Schultze, Achim Heinecke, Reza Parwaresch, Markus Tiemann, for the German Multicenter Study Group

From the Departments of Medicine, Hematology and Oncology, Radiation Oncology, and General Surgery, and Institute for Medical Informatics and Biomathematics, Westfälische-Wilhelms-Universität, Münster; Municipal Clinic, Department of Hematology/Oncology, and Pius-Hospital, Department of Radiooncology, Oldenburg; Department of Surgery, St-Antonius-Hospital, Kleve; Department of Medicine III–Großhadern, Ludwig-Maximilians-Universität, München; Department of Medicine/Gastroenterology and Oncology, Municipal Clinic, Dortmund; Departments of Medicine, Hematology and Oncology, and Radiation Oncology, Universität des Saarlands, Homburg; Departments of Gastroenterology and Radiation Oncology, Zentralklinikum, Augsburg; Department of Hematology/Oncology, Central Clinic, and Institute of Radiooncology, Minden; and Departments of Hematology/Oncology, Medical Clinic II, and Radiation Oncology, Christian-Albrechts-Universität, and Lymph Node Registry at the German Society of Pathology, Department of Hematopathology, Christian-Albrechts-Universität, Kiel, Germany.

Address reprint requests to Peter Koch, MD, Medizinische Klinik A, Westfälische-Wilhelms-Universität, Albert-Schweitzer-Strasse 33, 48149 Münster, Germany; email: prfkoch{at}aol.com

PURPOSE: The study was initiated to obtain epidemiologic data and information on anatomic and histologic distribution, clinical features, and treatment results in patients with primary gastrointestinal non-Hodgkin’s lymphomas (PGI NHL).

PATIENTS AND METHODS: Between October 1992 and November 1996, 371 PGI NHL patients were eligible to evaluate clinical features. Radiotherapy and chemotherapy were stratified according to histologic grading, stage, and whether surgery had been carried out or not.

RESULTS: A total of 74.8% patients had gastric NHL (PGL). Within the intestine, the small bowel and the ileocecal region were involved in 8.6% and 7.0% of the cases, respectively. Multiple GI involvement (MGI) was 6.5%. Approximately 90% of the GI NHL were in stages IE/IIE. Aggressive NHL accounted for the majority, with a distinguishable pattern in several sites. Forty percent of PGL were of low-grade mucosa-associated lymphatic tissue type. One third of large-cell lymphomas had low-grade components. Most intestinal NHL were germinal-center lymphomas. The site of origin was prognostic. In gastric and ileocecal lymphoma, event-free (EFS) and overall survival (OS) were significantly higher as compared with the small intestine or MGI (median time of observation, 51 months). In PGL, localized disease was prognostic for EFS and OS. Histologic grade influenced only EFS significantly. Numbers in intestinal lymphomas were too small for subanalyses.

CONCLUSION: PGI NHL are heterogeneous diseases. The number of localized PGL allowed for detailed analyses. Larger studies are needed for stages III and IV and for intestinal NHL. A uniform reporting system for PGI NHL, in terms of definitions and histologic and staging classifications, is needed to facilitate comparison of treatment results.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
A. Psyrri, S. Papageorgiou, and T. Economopoulos
Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management
Ann. Onc., December 1, 2008; 19(12): 1992 - 1999.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
D. G. Lohan, A. N. Alhajeri, C. G. Cronin, C. J. Roche, and J. M. Murphy
MR Enterography of Small-Bowel Lymphoma: Potential for Suggestion of Histologic Subtype and the Presence of Underlying Celiac Disease
Am. J. Roentgenol., February 1, 2008; 190(2): 287 - 293.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Koch, R. Liersch, N. A. Willich, G. Reinartz, and W. E. Berdel
In Reply:
J. Clin. Oncol., June 10, 2006; 24(17): 2682 - 2683.
[Full Text] [PDF]


Home page
JCOHome page
P. Koch, A. Probst, W. E. Berdel, N. A. Willich, G. Reinartz, J. Brockmann, R. Liersch, F. del Valle, H. Clasen, C. Hirt, et al.
Treatment Results in Localized Primary Gastric Lymphoma: Data of Patients Registered Within the German Multicenter Study (GIT NHL 02/96)
J. Clin. Oncol., October 1, 2005; 23(28): 7050 - 7059.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
T. Economopoulos, S. Papageorgiou, D. Rontogianni, V. Kaloutsi, G. Fountzilas, C. Tsatalas, N. Pavlidis, D. Pectasides, E. Papageorgiou, and M. Dimopoulos
Multifocal Extranodal Non-Hodgkin Lymphoma: A Clinicopathologic Study of 37 Cases in Greece, a Hellenic Cooperative Oncology Group Study
Oncologist, October 1, 2005; 10(9): 734 - 738.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. Alpen, R. Kuse, R. Parwaresch, H. K. Muller-Hermelink, M. Stolte, and A. Neubauer
Ongoing Monoclonal B-Cell Proliferation Is Not Common in Gastric B-Cell Lymphoma After Combined Radiochemotherapy
J. Clin. Oncol., August 1, 2004; 22(15): 3039 - 3045.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Daum, R. Ullrich, and M. Zeitz
In Reply:
J. Clin. Oncol., July 1, 2004; 22(13): 2753 - 2754.
[Full Text] [PDF]


Home page
JCOHome page
P. Koch, R. Liersch, and W.E. Berdel
Intestinal Non-Hodgkin's Lymphoma
J. Clin. Oncol., July 1, 2004; 22(13): 2752 - 2753.
[Full Text]


Home page
JCOHome page
S. Daum, R. Ullrich, W. Heise, B. Dederke, H.-D. Foss, H. Stein, E. Thiel, M. Zeitz, and E.-O. Riecken
Intestinal Non-Hodgkin's Lymphoma: A Multicenter Prospective Clinical Study From the German Study Group on Intestinal Non-Hodgkin's Lymphoma
J. Clin. Oncol., July 15, 2003; 21(14): 2740 - 2746.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
G. Damaj, V. Verkarre, A. Delmer, P. Solal-Celigny, I. Yakoub-Agha, C. Cellier, F. Maurschhauser, R. Bouabdallah, V. Leblond, F. Lefrere, et al.
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review
Ann. Onc., April 1, 2003; 14(4): 623 - 629.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Chenal, H. Molina, V. Mendez, J. Poole, and C. Parellada
Uncommon Presentations of Non-Hodgkin's Lymphoma: Case 2. Non-Hodgkin's Lymphoma of the Ileocecal Region
J. Clin. Oncol., February 1, 2003; 21(3): 565 - 567.
[Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
I. Kataoka, F. Arima, J. Nishimoto, T. Watanabe, Y. Kobayashi, R. Tamura, S. Yamamoto, Y. Matsuno, T. Shimoda, and K. Tobinai
Enteropathy-type T-cell Lymphoma Showing Repeated Small Bowel Rupture and Refractoriness to Chemotherapy: a Case Report
Jpn. J. Clin. Oncol., December 1, 2002; 32(12): 546 - 549.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Koch, F. del Valle, W. E. Berdel, N. A. Willich, B. Reers, W. Hiddemann, B. Grothaus-Pinke, G. Reinartz, J. Brockmann, A. Temmesfeld, et al.
Primary Gastrointestinal Non-Hodgkin's Lymphoma: II. Combined Surgical and Conservative or Conservative Management Only in Localized Gastric Lymphoma--Results of the Prospective German Multicenter Study GIT NHL 01/92
J. Clin. Oncol., September 15, 2001; 19(18): 3874 - 3883.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2001 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online